Clinical Trial Update: Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating testolactone for LHRH-resistant precocious puberty in girls has completed, with consideration of cases associated with polyo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polyostotic Fibrous Dysplasia
• Precocious Puberty

Drugs mentioned

• Testolactone (testolactone)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Polyostotic Fibrous Dysplasia, Precocious Puberty | Phase 2 | Status: COMPLETED